Dawn Halkuff

Insider Reports History

Location
C/O Xeris Pharmaceuticals, 180 N. Lasalle St., Ste. 1800, Chicago, IL
Signature
/s/ Beth Hecht, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dawn Halkuff:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xeris Biopharma Holdings, Inc. Director Common Stock 158K $1.22M $7.77 Jun 4, 2025 Direct
Xeris Biopharma Holdings, Inc. Director Common Stock 5.41K $42K $7.77 Jun 4, 2025 By; DAWN HALKUFF REVOCABLE TRUST U/A DTD 08/25/2017
XERIS PHARMACEUTICALS INC Director Stock Option (Right to Buy) 0 Oct 5, 2021 Direct

Insider Reports Filed by Dawn Halkuff

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XERS Xeris Biopharma Holdings, Inc. Aug 12, 2025 1 -$309K 4 Aug 13, 2025 Director
XERS Xeris Biopharma Holdings, Inc. Jun 4, 2025 1 $0 4 Jun 4, 2025 Director
XERS Xeris Biopharma Holdings, Inc. Jun 5, 2024 1 $0 4 Jun 5, 2024 Director
XERS Xeris Biopharma Holdings, Inc. Nov 20, 2023 1 $9.95K 4 Nov 21, 2023 Director
XERS Xeris Biopharma Holdings, Inc. Jun 7, 2023 1 $0 4 Jun 7, 2023 Director
XERS Xeris Biopharma Holdings, Inc. Jun 8, 2022 2 $0 4 Jun 9, 2022 Director
XERS Xeris Biopharma Holdings, Inc. Oct 5, 2021 4 $0 4 Oct 5, 2021 Director
XERS XERIS PHARMACEUTICALS INC Oct 5, 2021 4 $0 4 Oct 5, 2021 Director
XERS Xeris Biopharma Holdings, Inc. Oct 5, 2021 0 $0 3 Oct 5, 2021 Director
XERS XERIS PHARMACEUTICALS INC Jun 8, 2021 1 $0 4 Jun 8, 2021 Director